Chapter review

Must know

• Tricyclic Antidepressant (TCA) Cardiac RisksSource Scope Note: Fitzgerald Chapter 18 is not included in the provided notebook files (which cover Chapters 1 through 16), but tricyclic antidepressant (TCA) cardiac risks are extensively detailed in Fitzgerald Chapters 2, 8, and 9.

  • Source Scope Note: Fitzgerald Chapter 18 is not included in the provided notebook files (which cover Chapters 1 through 16), but tricyclic antidepressant (TCA) cardiac risks are extensively detailed in Fitzgerald Chapters 2, 8, and 9.
  • Electrophysiological Mechanism: TCAs exert quinidine-like Class IA antiarrhythmic actions and block fast sodium channels, slowing cardiac conduction velocity and prolonging PR, QRS, and QTc intervals.
  • QRS Duration Thresholds: A QRS duration exceeding 100 milliseconds indicates an elevated risk for seizures, while a QRS duration exceeding 160 milliseconds predicts a high risk for lethal ventricular arrhythmias, including ventricular tachycardia and torsades de pointes.
  • Absolute Contraindications: Recent myocardial infarction, acute post-MI recovery phase, second-degree or third-degree heart block, severe bundle branch block, or existing baseline QTc prolongation are strict contraindications to TCA therapy.
  • Autonomic Cardiac Effects: Alpha-1 adrenergic receptor blockade by TCAs causes significant orthostatic hypotension and reflex tachycardia, while muscarinic anticholinergic blockade causes persistent sinus tachycardia.
  • Lethality in Overdose: TCAs have a narrow therapeutic index, and an acute overdose of as little as a 10-day supply (1 gram) can cause rapid fatal cardiac toxicity and sudden death.
• Electrophysiology and Conduction BlockadeObtaining a baseline 12-lead ECG prior to prescribing is the mandatory first-line safety step.

  • What it is: TCAs inhibit cardiac fast sodium channels (Class IA antiarrhythmic effect) and delayed rectifier potassium channels, delaying cardiac depolarization and repolarization.
  • Why boards care: TCA cardiotoxicity is a leading cause of fatal drug overdose in psychiatric practice.
  • Normal QRS is less than 100 milliseconds. QRS between 100 and 160 milliseconds indicates moderate toxicity. QRS greater than 160 milliseconds indicates severe toxicity.
  • Typical board clue: A depressed patient presenting after an ingestion with confusion, dry mouth, dilated pupils, hypotension, and a widened QRS complex on ECG.
  • Obtaining a baseline 12-lead ECG prior to prescribing is the mandatory first-line safety step.
  • When the answer changes: If the stem describes an acute overdose with QRS widening greater than 100 milliseconds, the first-line intervention changes to immediate intravenous sodium bicarbonate administration to alkalinize the serum and unbind the drug from sodium channels.

  Safety. Never prescribe TCAs to patients with active suicidal ideation or a history of serious suicide attempts due to extreme lethality in overdose.

• Autonomic Cardiac Adverse EffectsAlpha-1 Adrenergic Blockade: Causes peripheral vasodilation leading to orthostatic hypotension, dizziness, and reflex tachycardia. This is particularly dangerous in older adults due to elevated fall and fracture risks.

  • Alpha-1 Adrenergic Blockade: Causes peripheral vasodilation leading to orthostatic hypotension, dizziness, and reflex tachycardia. This is particularly dangerous in older adults due to elevated fall and fracture risks.
  • Muscarinic Anticholinergic Blockade: Inhibits vagal tone, causing persistent sinus tachycardia.
  • Mistaking TCA induced sinus tachycardia or orthostatic dizziness for worsening anxiety or panic disorder, leading to inappropriate dose escalation instead of discontinuation.

  Board trap. Mistaking TCA induced sinus tachycardia or orthostatic dizziness for worsening anxiety or panic disorder, leading to inappropriate dose escalation instead of discontinuation.

• TCAs vs. SSRIs Cardiac Safety ProfileThink TCAs: Quinidine-like sodium channel blockade, significant conduction delays, high risk of fatal arrhythmias in overdose, mandatory baseline ECG.

  • Think TCAs: Quinidine-like sodium channel blockade, significant conduction delays, high risk of fatal arrhythmias in overdose, mandatory baseline ECG.
  • Think SSRIs: Favorable overall cardiovascular safety profile, minimal conduction interference, safe in mild overdose. (Note: citalopram requires dose capping at 20 mg daily in patients over age 60 due to dose-dependent QTc prolongation).
  • Priority difference: TCAs require pre-treatment cardiac screening and strict toxicity monitoring. SSRIs are the preferred first-line choice for patients with comorbid cardiovascular disease.
  • What boards are really testing: Selecting cardiosafe antidepressant agents in patients with pre-existing heart disease or elevated suicide risk.
• QRS Interval Risk Tiers in TCA ToxicityQRS less than 100 ms: Normal cardiac conduction; low risk of acute life-threatening arrhythmia.

  • QRS less than 100 ms: Normal cardiac conduction; low risk of acute life-threatening arrhythmia.
  • QRS 100 to 160 ms: Moderate toxicity; significantly increased risk for grand mal seizures.
  • QRS greater than 160 ms: Severe cardiotoxicity; high risk for ventricular tachycardia, torsades de pointes, and cardiovascular collapse.
  • What boards are really testing: Identifying QRS width as the key diagnostic and prognostic marker driving emergency therapy in TCA overdose.
• Common Board TrapsThe Youth Assumption Trap: Assuming a young or physically active patient with depression does not require a baseline ECG before starting a TCA. National standards require baseline cardiac screening regardless of age when initiating cardiotoxic agents.

  • The Youth Assumption Trap: Assuming a young or physically active patient with depression does not require a baseline ECG before starting a TCA. National standards require baseline cardiac screening regardless of age when initiating cardiotoxic agents.
  • The Refractory Escalation Trap: Escalating the dose of amitriptyline or imipramine when a patient reports persistent palpitations or dizziness. These are direct toxic anticholinergic and alpha-blockade side effects, not undertreated anxiety.
  • Choosing Dialysis in Toxicity: Selecting hemodialysis or hemoperfusion for acute TCA overdose. TCAs are highly protein-bound with a large volume of distribution, making dialysis ineffective. The correct emergency treatment is intravenous sodium bicarbonate.
• Active Recall Checkpoints1. What baseline diagnostic test must be performed before starting any patient on a tricyclic antidepressant?

  • 1. What baseline diagnostic test must be performed before starting any patient on a tricyclic antidepressant?
  • 2. What QRS duration threshold on an ECG indicates a high risk for seizures in TCA overdose?
  • 3. What QRS duration threshold indicates a high risk for life-threatening ventricular arrhythmias in TCA overdose?
  • 4. What receptor blockade is responsible for TCA induced orthostatic hypotension?
  • 5. What is the emergency pharmacological treatment of choice for TCA induced cardiotoxicity and QRS prolongation?
• Lithium Cardiac ImpactsObtain baseline ECG, serum creatinine, eGFR, BUN, TSH, and serum hCG prior to initiating lithium therapy.

  • Obtain baseline ECG, serum creatinine, eGFR, BUN, TSH, and serum hCG prior to initiating lithium therapy.
  • Lithium induces benign, reversible T-wave flattening or T-wave inversion on ECG in up to 30 percent of patients at therapeutic doses.
  • Lithium depresses sinus node automaticity, creating risks for sinus bradycardia, sinoatrial block, or AV block in susceptible individuals.
  • First-trimester pregnancy exposure to lithium increases the risk of Ebstein anomaly, a severe congenital tricuspid valve malformation.
  • Therapeutic serum levels range from 0.6 to 1.2 mEq/L for maintenance, while levels at or above 1.5 mEq/L cause toxic cardiac and neurological manifestations.
  • Adjusting lithium dosing in an established diagnosis of bipolar disorder is classified as tertiary prevention.
• Safety AlertFirst-trimester pregnancy exposure to lithium carries a high-yield board risk for Ebstein anomaly, characterized by downward displacement of the tricuspid valve into the right ventricle and right atrial enlargement.

  • First-trimester pregnancy exposure to lithium carries a high-yield board risk for Ebstein anomaly, characterized by downward displacement of the tricuspid valve into the right ventricle and right atrial enlargement.
  • Severe toxicity with a serum level at or above 1.5 to 2.0 mEq/L can trigger sinus node arrest, severe bradycardia, ventricular arrhythmias, and profound neurological collapse.
• Board TrapMistaking benign T-wave flattening or inversion on ECG for acute myocardial ischemia, leading to unnecessary emergency referrals or premature discontinuation of lithium.

  • Mistaking benign T-wave flattening or inversion on ECG for acute myocardial ischemia, leading to unnecessary emergency referrals or premature discontinuation of lithium.
  • Failing to order a baseline ECG before prescribing lithium, which misses pre-existing sick sinus syndrome or conduction blocks.
• First-LineLithium remains a first-line mood stabilizer for acute mania and maintenance in bipolar I disorder, provided baseline cardiac, renal, thyroid, and pregnancy screening is completed first.

  • Lithium remains a first-line mood stabilizer for acute mania and maintenance in bipolar I disorder, provided baseline cardiac, renal, thyroid, and pregnancy screening is completed first.
• Cardiac Findings and Laboratory Workup SynthesisBaseline cardiac and metabolic evaluation: Before starting lithium, order an ECG to evaluate baseline rhythm and conduction, along with renal function tests (eGFR and creatinine), thyroid panel (TSH), serum electrolytes, and pregnancy test (hCG).

  • Baseline cardiac and metabolic evaluation: Before starting lithium, order an ECG to evaluate baseline rhythm and conduction, along with renal function tests (eGFR and creatinine), thyroid panel (TSH), serum electrolytes, and pregnancy test (hCG).
  • Conduction effects: Lithium replaces intracellular potassium in cardiac myocytes, altering repolarization. This produces benign T-wave flattening or inversion on ECG, while depressing sinus node pacemaking function.
  • High-risk populations: Older adults and patients with underlying sick sinus syndrome or AV node disease face heightened risk for severe sinus bradycardia and sinoatrial block when taking lithium.
• Anorexia Nervosa Cardiovascular SignsAnorexia Nervosa causes severe, life-threatening cardiovascular complications due to starvation-induced myocardial atrophy, autonomic dysregulation, and electrolyte depletion.

  • Anorexia Nervosa causes severe, life-threatening cardiovascular complications due to starvation-induced myocardial atrophy, autonomic dysregulation, and electrolyte depletion.
  • Cardinal cardiovascular signs include sinus bradycardia with a resting heart rate below 50 beats per minute, hypotension with blood pressure below 90/60 mmHg, and QTc prolongation on ECG.
  • Functional mitral valve prolapse occurs in up to 30 percent to 60 percent of severe cases due to a disproportion between a shrunken left ventricle and normal valve leaflet size.
  • Electrolyte derangements, specifically hypokalemia and hypomagnesemia from starvation or purging, drive QTc prolongation and fatal ventricular arrhythmias like Torsades de Pointes.
  • Immediate medical hospitalization is indicated when resting heart rate drops below 40 beats per minute, blood pressure drops below 90/60 mmHg, temperature falls below 36 degrees Celsius (96.8 degrees Fahrenheit), or QTc interval exceeds 450 milliseconds.
  • Bupropion is strictly contraindicated in eating disorders due to an elevated risk of drug-induced seizures.
• High-Yield Clinical TeachingPathophysiology of Myocardial Atrophy

  • Pathophysiology of Myocardial Atrophy
  • Autonomic Dysregulation and Vital Sign Depression
  • Electrophysiological Instability
  • Functional Valvular Changes
• Spoken Review of Cardiac Findings and MonitoringOutpatient management is appropriate when resting heart rate remains above 50 beats per minute, systolic blood pressure stays above 90/60 mmHg, and body weight is above 85 percent of ideal body weight.

  • Outpatient management is appropriate when resting heart rate remains above 50 beats per minute, systolic blood pressure stays above 90/60 mmHg, and body weight is above 85 percent of ideal body weight.
  • Immediate inpatient medical hospitalization is required when resting heart rate drops below 40 beats per minute, systolic blood pressure drops below 90 mmHg, QTc interval exceeds 450 milliseconds, or body weight falls below 75 percent of ideal body weight (or BMI is below 15).
• Bulimia Nervosa Cardiac ComplicationsBaseline ECG, eGFR, serum creatinine, and TSH are required prior to initiating lithium therapy.

  • ANCC and AANPCB board exams evaluate cardiovascular and body system considerations across all domains, representing up to 22% of scientific foundation items.
  • Baseline ECG, eGFR, serum creatinine, and TSH are required prior to initiating lithium therapy.
  • Citalopram is capped at a maximum daily dose of 20 mg in adults aged 60 and older due to dose-dependent QTc prolongation risk.
  • Clozapine carries FDA black box warnings for myocarditis and cardiomyopathy, requiring immediate drug cessation if dyspnea, fever, chest pain, or palpitations develop.
  • Tricyclic antidepressants require baseline ECG and ongoing monitoring because overdose carries a high risk of fatal ventricular arrhythmias and heart block.
  • Do not diagnose a primary anxiety or panic disorder without first ruling out medical cardiovascular mimics such as myocardial infarction, pulmonary embolism, or pheochromocytoma.

  Board trap. Tricyclic antidepressants require baseline ECG and ongoing monitoring because overdose carries a high risk of fatal ventricular arrhythmias and heart block.

  Safety. ANCC and AANPCB board exams evaluate cardiovascular and body system considerations across all domains, representing up to 22% of scientific foundation items.

• QT Prolongation Risk ProfileCitalopram has an FDA dose ceiling of 20 mg daily in adults aged 60 years and older (and poor CYP2C19 metabolizers) due to dose-dependent QTc prolongation and Torsades de Pointes risk.

  • Citalopram has an FDA dose ceiling of 20 mg daily in adults aged 60 years and older (and poor CYP2C19 metabolizers) due to dose-dependent QTc prolongation and Torsades de Pointes risk.
  • Tricyclic antidepressants (TCAs) cause QTc prolongation, heart block, and lethal ventricular arrhythmias in overdose by blocking cardiac fast sodium channels. A baseline electrocardiogram (ECG) is mandatory before starting TCAs.
  • Clozapine carries a black box warning for myocarditis and cardiomyopathy, which most often develops during the first 6 weeks of treatment. Immediate cessation is required for unexplained fever, chest pain, dyspnea, tachycardia, or fatigue.
  • Thioridazine and intravenous haloperidol carry the highest QTc prolongation risk among antipsychotics. Other notable high-risk agents include ziprasidone, pimozide, and methadone.
  • Lithium requires a baseline ECG along with renal (eGFR, serum creatinine), thyroid (TSH), and pregnancy testing due to potential sinus node dysfunction.
  • Anorexia nervosa causes severe physical cardiovascular complications including sinus bradycardia, hypotension, QTc prolongation, and mitral valve prolapse.
• QTc Prolongation Risk ProfileAssess baseline cardiac history, personal or family history of syncope or sudden death, serum potassium, and serum magnesium before starting high-risk psychotropics.

  • Normal QTc intervals are under 450 ms for men and 470 ms for women. A QTc interval exceeding 500 ms or an increase greater than 60 ms from baseline represents an extreme hazard for Torsades de Pointes and sudden cardiac death.
  • Assess baseline cardiac history, personal or family history of syncope or sudden death, serum potassium, and serum magnesium before starting high-risk psychotropics.

  Safety. Normal QTc intervals are under 450 ms for men and 470 ms for women. A QTc interval exceeding 500 ms or an increase greater than 60 ms from baseline represents an extreme hazard for Torsades de Pointes and sudden cardiac death.

• CitalopramCap citalopram at 20 mg daily for adults over age 60, patients with hepatic impairment, or poor CYP2C19 metabolizers. Maximum dose in younger adults is 40 mg daily.

  • What it is: An SSRI antidepressant.
  • Why boards care: It exhibits dose-dependent QTc prolongation.
  • Cap citalopram at 20 mg daily for adults over age 60, patients with hepatic impairment, or poor CYP2C19 metabolizers. Maximum dose in younger adults is 40 mg daily.
  • Choosing citalopram 40 mg daily for an elderly patient with major depression. The correct choice is capping at 20 mg or selecting sertraline or escitalopram.

  Board trap. Choosing citalopram 40 mg daily for an elderly patient with major depression. The correct choice is capping at 20 mg or selecting sertraline or escitalopram.

• Tricyclic Antidepressants (TCAs)Obtain a baseline ECG in all patients prior to initiating TCAs.

  • What it is: Non-selective monoamine reuptake inhibitors including amitriptyline, nortriptyline, and imipramine.
  • Why boards care: High cardiotoxicity and lethality in overdose.
  • TCAs slow cardiac conduction, widening the QRS complex and prolonging the QTc interval, leading to heart block and fatal ventricular arrhythmias.
  • Obtain a baseline ECG in all patients prior to initiating TCAs.

  Safety. TCAs slow cardiac conduction, widening the QRS complex and prolonging the QTc interval, leading to heart block and fatal ventricular arrhythmias.

• ClozapineDiscontinue clozapine immediately if myocarditis or cardiomyopathy is suspected and refer to the emergency department.

  • What it is: A second-generation antipsychotic (SGA) for treatment-resistant schizophrenia.
  • Why boards care: Multiple black box warnings including agranulocytosis, seizures, myocarditis, and orthostasis.
  • Myocarditis presents during the first 6 weeks of therapy with unexplained fever, chest pain, dyspnea, palpitations, or fatigue.
  • Discontinue clozapine immediately if myocarditis or cardiomyopathy is suspected and refer to the emergency department.

  Safety. Myocarditis presents during the first 6 weeks of therapy with unexplained fever, chest pain, dyspnea, palpitations, or fatigue.

• Anorexia Nervosa Cardiovascular FeaturesInpatient hospitalization is required if heart rate is below 40 bpm, blood pressure is below 90/60 mmHg, or severe cardiac arrhythmias occur.

  • What it is: An eating disorder characterized by severe restriction and low body mass.
  • Why boards care: Severe physical and cardiac instability.
  • Must-know features: Starvation causes sinus bradycardia, hypotension, QTc prolongation, and mitral valve prolapse.
  • Inpatient hospitalization is required if heart rate is below 40 bpm, blood pressure is below 90/60 mmHg, or severe cardiac arrhythmias occur.
• Citalopram vs. Sertraline in Older AdultsDo not confuse: Both are effective SSRIs, but their cardiac safety boundaries differ in late-life depression.

  • Do not confuse: Both are effective SSRIs, but their cardiac safety boundaries differ in late-life depression.
  • Think Citalopram when: Dosing must be capped at 20 mg daily in patients over age 60 due to QTc prolongation risks.
  • Think Sertraline when: Preferred first-line SSRI in older adults or post-myocardial infarction patients due to minimal QTc impact.
  • Priority difference: Citalopram has a strict FDA dose ceiling in older adults; sertraline lacks this specific QTc restriction.
• Myocarditis vs. Neuroleptic Malignant Syndrome on ClozapineDo not confuse: Both cause fever and tachycardia in a patient taking an antipsychotic.

  • Do not confuse: Both cause fever and tachycardia in a patient taking an antipsychotic.
  • Think Myocarditis when: Chest pain, dyspnea, elevated troponin, and fatigue develop within the first 6 weeks of starting clozapine.
  • Think NMS when: Severe lead-pipe muscle rigidity, autonomic instability, diaphoresis, and elevated CK occur.
  • Priority difference: Myocarditis directly inflames cardiac muscle tissue; NMS presents with generalized muscular rigidity and hyperthermia.
• Key ClueA: Citalopram 40 mg daily exceeds the maximum recommended dose for patients over age 60 and elevates QTc prolongation risk.

  • A: Citalopram 40 mg daily exceeds the maximum recommended dose for patients over age 60 and elevates QTc prolongation risk.
  • B: Correct choice.
  • C: Amitriptyline is a TCA that carries high cardiotoxicity, anticholinergic side effects, and orthostasis risks in older adults, requiring a baseline ECG.
  • D: Thioridazine is a first-generation antipsychotic with a black box warning for QTc prolongation and is not indicated for uncomplicated major depressive disorder.
• Citalopram Dosing LimitsThe PMHNP certification examination evaluates entry-level knowledge and clinical decision-making skills required for safe practice across all physical body systems, including the cardiovascular system.

  • The PMHNP certification examination evaluates entry-level knowledge and clinical decision-making skills required for safe practice across all physical body systems, including the cardiovascular system.
  • Primary prevention aims to prevent a health problem before it occurs and is the most cost-effective healthcare strategy.
  • Secondary prevention focuses on early detection through screening in asymptomatic or preclinical stages to minimize disease impact.
  • Tertiary prevention manages established disease to avoid further target organ damage or clinical complications.
  • ANCC exam architecture contains 175 total items (150 scored, 25 unscored pretest) over 3.5 hours.
  • AANPCB exam architecture contains 150 total items (135 scored, 15 unscored pretest) over 3.0 hours.
• Cardiovascular Systems in Board BlueprintsPMHNP certification blueprints test physical assessment skills and secondary body system classifications, specifically including the cardiovascular system.

  • PMHNP certification blueprints test physical assessment skills and secondary body system classifications, specifically including the cardiovascular system.
  • Clinical scenarios require PMHNPs to evaluate general medical conditions and medication effects alongside primary psychiatric diagnoses.
• Levels of Prevention FrameworkPrimary Prevention: Interventions performed before disease occurs. Examples include administering the influenza vaccine, providing safety education, conducting parenting classes for newborn stress, and counseling on STI prevention.

  • Primary Prevention: Interventions performed before disease occurs. Examples include administering the influenza vaccine, providing safety education, conducting parenting classes for newborn stress, and counseling on STI prevention.
  • Secondary Prevention: Screening and early detection of asymptomatic disease. Examples include administering the PHQ-9 depression screen, checking blood pressure or lipid panels, facilitating mammograms, and screening for physical or financial abuse.
• Primary PreventionThink: Preventing disease before onset.

  • Think: Preventing disease before onset.
  • Priority: Health promotion, injury prevention, and immunizations.
  • Boards are testing: Recognizing proactive measures taken in healthy populations.
• Secondary PreventionThink: Early screening and detection.

  • Think: Early screening and detection.
  • Priority: Identifying asymptomatic disease early.
  • Boards are testing: Selecting screening tools such as the PHQ-9, lipid panels, or abuse screens.
• Tertiary PreventionThink: Managing chronic, established illness.

  • Think: Managing chronic, established illness.
  • Priority: Preventing target organ damage and disease progression.
  • Boards are testing: Adjusting psychotropic medications like lithium for existing conditions.
• Common Traps and Safety PearlsPrimary prevention represents the most cost-effective form of healthcare intervention.

  • Always intervene at the lowest level of prevention possible in primary care and psychiatric practice.
  • Mistaking a screening tool for tertiary management. Administering a PHQ-9 to detect depression is secondary prevention, whereas adjusting antidepressant therapy for established depression is tertiary prevention.
  • Primary prevention represents the most cost-effective form of healthcare intervention.

  Board trap. Mistaking a screening tool for tertiary management. Administering a PHQ-9 to detect depression is secondary prevention, whereas adjusting antidepressant therapy for established depression is tertiary prevention.

  Safety. Always intervene at the lowest level of prevention possible in primary care and psychiatric practice.

• Clozapine Black Box WarningsClozapine carries five FDA black box warnings: severe neutropenia, orthostatic hypotension/bradycardia/syncope, seizures, myocarditis/cardiomyopathy, and increased mortality in elderly patients with dementia-related psychosis.

  • Clozapine carries five FDA black box warnings: severe neutropenia, orthostatic hypotension/bradycardia/syncope, seizures, myocarditis/cardiomyopathy, and increased mortality in elderly patients with dementia-related psychosis.
  • Clozapine causes potentially fatal myocarditis and cardiomyopathy, requiring immediate discontinuation if a patient develops unexplained fatigue, dyspnea, tachypnea, fever, chest pain, or palpitations.
  • Severe neutropenia monitoring for clozapine requires a baseline absolute neutrophil count (ANC) of at least 1500/mm3 for the general population and at least 1000/mm3 for individuals with benign ethnic neutropenia.
  • Clozapine titration must proceed slowly to prevent severe orthostatic hypotension, bradycardia, and syncope during initial dosing.
  • Citalopram has an FDA dose ceiling of 20 mg daily in adults over age 60 due to dose-dependent QTc prolongation and risk of Torsades de Pointes.
  • Tricyclic antidepressants require a baseline ECG prior to initiation due to risks of QTc prolongation, heart block, and fatal ventricular arrhythmias in overdose.
• QTc Prolongation and Antidepressant SelectionObtain a baseline ECG before starting tricyclic antidepressants. Limit citalopram to a maximum dose of 20 mg daily in patients aged 60 and older.

  • What it is: Delayed ventricular repolarization that increases the risk of Torsades de Pointes and sudden cardiac death.
  • Tricyclic antidepressants and high-dose citalopram significantly prolong the QTc interval.
  • Obtain a baseline ECG before starting tricyclic antidepressants. Limit citalopram to a maximum dose of 20 mg daily in patients aged 60 and older.
  • Prescribing citalopram 40 mg daily to an older adult with depression. The correct action is to limit the daily dose to 20 mg or switch to sertraline or escitalopram.

  Board trap. Prescribing citalopram 40 mg daily to an older adult with depression. The correct action is to limit the daily dose to 20 mg or switch to sertraline or escitalopram.

  Safety. Tricyclic antidepressants and high-dose citalopram significantly prolong the QTc interval.

• Cardiovascular Screening in ADHD and AnorexiaPerform a targeted personal and family cardiac history and vital sign assessment before initiating methylphenidate or amphetamine salts.

  • What it is: Cardiac assessment required before initiating central nervous system stimulants or managing severe eating disorders.
  • Stimulants increase heart rate and blood pressure and can trigger sudden cardiac death in patients with underlying structural heart defects.
  • Perform a targeted personal and family cardiac history and vital sign assessment before initiating methylphenidate or amphetamine salts.
  • Ordering a routine baseline ECG for every child before starting a stimulant. An ECG is indicated only if the cardiac history or physical exam reveals red flags, such as unexplained syncope, chest pain, or a family history of sudden premature cardiac death.

  Board trap. Ordering a routine baseline ECG for every child before starting a stimulant. An ECG is indicated only if the cardiac history or physical exam reveals red flags, such as unexplained syncope, chest pain, or a family history of sudden premature cardiac death.

  Safety. Stimulants increase heart rate and blood pressure and can trigger sudden cardiac death in patients with underlying structural heart defects.

• Clozapine vs Other Second-Generation AntipsychoticsDo not confuse: Clozapine with routine atypical antipsychotics like risperidone or olanzapine.

  • Do not confuse: Clozapine with routine atypical antipsychotics like risperidone or olanzapine.
  • Think Clozapine when: A patient has treatment-resistant schizophrenia or severe recurrent suicidality, requiring strict ANC monitoring and vigilance for myocarditis.
  • Think Other SGAs when: Initiating first-line treatment for acute psychosis or bipolar mania.
  • Priority difference: Clozapine carries unique black box warnings for fatal myocarditis and severe neutropenia.
  • What boards are testing: Recognizing when treatment resistance warrants clozapine and identifying its life-threatening adverse effects.
• Myocarditis vs Neuroleptic Malignant SyndromeDo not confuse: Clozapine-induced myocarditis with neuroleptic malignant syndrome.

  • Do not confuse: Clozapine-induced myocarditis with neuroleptic malignant syndrome.
  • Think Myocarditis when: A patient taking clozapine presents with chest pain, dyspnea, palpitations, fever, and fatigue, typically within the first 4 to 6 weeks of treatment.
  • Think NMS when: A patient on any antipsychotic presents with severe muscle lead-pipe rigidity, high fever, autonomic instability, elevated creatine kinase, and altered mental status.
  • Priority difference: Both are medical emergencies requiring immediate drug discontinuation, but myocarditis specifically targets cardiac tissue function.
  • What boards are testing: Immediate drug cessation upon recognizing cardiovascular or systemic toxicity.
• Orthostatic and Vital Sign ChangesThe PMHNP certification exams explicitly test secondary classifications, including the cardiovascular system and non-psychiatric drug classes.

  • The PMHNP certification exams explicitly test secondary classifications, including the cardiovascular system and non-psychiatric drug classes.
  • Blood pressure checks and routine vital sign screenings represent secondary prevention aimed at detecting asymptomatic cardiovascular disease early.
  • Primary prevention focuses on preventing cardiovascular and systemic illness before onset, such as lifestyle and exercise counseling.
  • Tertiary prevention involves adjusting established medication regimens (such as lithium or cardiovascular drugs) to prevent target organ damage.
  • The ANCC exam consists of 175 total questions (150 scored, 25 unscored) over 3.5 hours.
  • The AANPCB exam consists of 150 total questions (135 scored, 15 unscored) over 3 hours.
• Sample Question 1A. Primary prevention

  • A. Primary prevention
  • B. Secondary prevention
  • C. Tertiary prevention
  • D. Anticipatory guidance
• Sample Question 2A. Primary prevention

  • A. Primary prevention
  • B. Secondary prevention
  • C. Tertiary prevention
  • D. Health promotion
• Baseline ECG RequirementsTricyclic Antidepressants (TCAs): Require a baseline ECG for all patients prior to initiation due to risks of QTc prolongation, heart block, and fatal arrhythmias in overdose.

  • Tricyclic Antidepressants (TCAs): Require a baseline ECG for all patients prior to initiation due to risks of QTc prolongation, heart block, and fatal arrhythmias in overdose.
  • Citalopram: Maximum dose is 40 mg daily in adults under 60, but it is capped at 20 mg daily in adults aged 60 and older due to dose-dependent QTc prolongation.
  • Lithium: Baseline workup requires an ECG (especially in patients over age 40 or with cardiac history), eGFR, serum creatinine, TSH, and pregnancy testing due to risks of sinus node dysfunction.
  • Clozapine: Carries a black box warning for myocarditis and cardiomyopathy. Baseline ECG and troponin are recommended, with immediate drug discontinuation if chest pain, dyspnea, or fever occur.
  • IV Haloperidol: IV administration carries a high risk of Torsades de Pointes. Continuous ECG monitoring is mandatory.
  • Stimulants: Require baseline blood pressure, heart rate, and personal or family cardiac history screening to rule out sudden cardiac death risk prior to treating ADHD.
• Selective Serotonin Reuptake Inhibitors (SSRIs)Must-know criteria: Dose-dependent QTc prolongation.

  • Must-know criteria: Dose-dependent QTc prolongation.
  • Geriatric threshold: Maximum dose is 20 mg daily in patients over age 60 or those with hepatic impairment.
  • If the QTc interval exceeds 500 milliseconds, stop the medication or reduce the dose immediately to prevent Torsades de Pointes.
  • Prescribing citalopram 40 mg daily to a 65-year-old patient. The maximum safe geriatric dose is 20 mg daily.

  Board trap. Prescribing citalopram 40 mg daily to a 65-year-old patient. The maximum safe geriatric dose is 20 mg daily.

  Safety. If the QTc interval exceeds 500 milliseconds, stop the medication or reduce the dose immediately to prevent Torsades de Pointes.

• Antipsychotics (FGAs and SGAs)Require continuous ECG telemetry monitoring during IV administration.

  • Carries black box warnings for myocarditis and cardiomyopathy. Highest risk occurs during the first 4 to 6 weeks of treatment.
  • When to stop: Discontinue clozapine permanently if the patient develops persistent unexplained tachycardia, chest pain, dyspnea, fever, or elevated troponin.
  • High risk for QTc prolongation and Torsades de Pointes.
  • Require continuous ECG telemetry monitoring during IV administration.
  • Ziprasidone and Thioridazine:
  • Must-know criteria: Require baseline ECG and electrolyte screening (potassium and magnesium) due to elevated QTc prolongation risk.

  Safety. Carries black box warnings for myocarditis and cardiomyopathy. Highest risk occurs during the first 4 to 6 weeks of treatment.

• Mood Stabilizers: LithiumObtain baseline ECG, eGFR, serum creatinine, TSH, and serum electrolytes before starting lithium.

  • Must-know criteria: Lithium can depress the sinus node, causing sinus bradycardia or sinoatrial block.
  • Obtain baseline ECG, eGFR, serum creatinine, TSH, and serum electrolytes before starting lithium.
  • Check lithium levels and ECG if the patient reports unexplained syncope, palpitations, or severe bradycardia.

  Safety. Check lithium levels and ECG if the patient reports unexplained syncope, palpitations, or severe bradycardia.

• ADHD Stimulants (Methylphenidate and Amphetamines)Screen for personal history of exertional chest pain, unexplained syncope, or family history of sudden cardiac death or hypertrophic cardiomyopathy.

  • Screen for personal history of exertional chest pain, unexplained syncope, or family history of sudden cardiac death or hypertrophic cardiomyopathy.
  • When to refer: Refer the patient for a cardiology consultation and baseline ECG before prescribing stimulants if cardiac risk factors or structural heart defects are identified.
• Clozapine Discontinuation CriteriaClozapine carries black box warnings for severe agranulocytosis, myocarditis, cardiomyopathy, seizures, and orthostatic hypotension.

  • Clozapine carries black box warnings for severe agranulocytosis, myocarditis, cardiomyopathy, seizures, and orthostatic hypotension.
  • Myocarditis alert: Risk is highest in the first 4 to 6 weeks of treatment. Immediately stop clozapine, order an ECG and troponin, and refer for emergency care if a patient develops unexplained fever, fatigue, dyspnea, tachypnea, chest pain, or palpitations.
  • Baseline ANC threshold: Baseline Absolute Neutrophil Count (ANC) must be 1,500/mcL or higher for the general population before starting clozapine.
  • Moderate neutropenia threshold: Withhold clozapine if ANC drops between 500/mcL and 999/mcL, and order daily ANC monitoring until counts recover to 1,000/mcL or higher.
  • Severe neutropenia threshold: Permanently discontinue clozapine if ANC falls below 500/mcL to prevent fatal agranulocytosis.
  • Benign Ethnic Neutropenia (BEN): Baseline ANC requirement is 1,000/mcL or higher, and discontinuation occurs when ANC falls below 500/mcL.
• Clozapine MyocarditisThink: Chest pain, dyspnea, fever, and tachycardia in weeks 1 to 6

  • Think: Chest pain, dyspnea, fever, and tachycardia in weeks 1 to 6
  • Priority: Immediate drug cessation, ECG, troponin, and emergency department referral
  • Boards are testing: Recognizing physical signs of life-threatening drug-induced cardiac inflammation
• Clozapine AgranulocytosisThink: ANC drop below 500/mcL, severe sore throat, and high fever

  • Think: ANC drop below 500/mcL, severe sore throat, and high fever
  • Priority: Immediate drug cessation, daily ANC checks, and hematology consultation
  • Boards are testing: Precision recall of national REMS ANC discontinuation cutoffs
• ANC result of 850/mcLWhy It Is Correct

  • Why It Is Correct
  • Why the Other Choices Are Wrong
  • A: Continuing clozapine without intervention during moderate neutropenia risks progression to fatal agranulocytosis.
  • C: Permanent discontinuation is mandatory when ANC drops below 500/mcL, not for moderate neutropenia of 850/mcL.
  • D: Doubling the dose is unsafe and contraindicated when neutropenia is present.
  • Test-Taking Pearl
• Citalopram Safety Thresholdscitalopram carries a maximum FDA daily dose ceiling of 40 mg for adults under age 60 due to dose-dependent QTc prolongation.

  • citalopram carries a maximum FDA daily dose ceiling of 40 mg for adults under age 60 due to dose-dependent QTc prolongation.
  • citalopram maximum daily dose is 20 mg for adults aged 60 and older, patients with hepatic impairment, CYP2C19 poor metabolizers, or those taking CYP2C19 inhibitors.
  • QTc interval greater than 500 ms or an increase greater than 60 ms from baseline requires immediate discontinuation of citalopram and urgent cardiac evaluation.
  • First-line action prior to initiating citalopram in patients with cardiac risk factors, or upon presentation of syncope or palpitations, is ordering a 12-lead ECG and checking serum potassium and magnesium levels.
  • Electrolyte abnormalities, specifically hypokalemia and hypomagnesemia, significantly increase the risk of Torsades de Pointes when combined with citalopram.
  • escitalopram has a lower overall risk of QTc prolongation than citalopram, with maximum daily thresholds of 20 mg in younger adults and 10 mg in adults aged 60 and older.

  Board trap. Selecting a dose increase above 20 mg daily for an older adult with unmanaged depression is a major safety violation on national board exams.

• QTc Monitoring and Actionable ThresholdsThe first-line intervention for any patient taking citalopram who reports new-onset syncope, presyncope, severe dizziness, or chest palpitations is obtaining an emergency ECG and drawing a basic metabolic panel (BMP) with magnesium.

  • A baseline 12-lead ECG should be obtained before starting citalopram in patients with congestive heart failure, bradyarrhythmias, a history of long QTc syndrome, or concurrent use of other QTc-prolonging psychotropics such as thioridazine, ziprasidone, or haloperidol.
  • If the post-treatment QTc interval exceeds 500 ms, or if the QTc interval prolongs by more than 60 ms from baseline, the PMHNP must immediately discontinue citalopram, evaluate serum electrolytes, and order a cardiology consultation.
  • The first-line intervention for any patient taking citalopram who reports new-onset syncope, presyncope, severe dizziness, or chest palpitations is obtaining an emergency ECG and drawing a basic metabolic panel (BMP) with magnesium.

  Safety. A baseline 12-lead ECG should be obtained before starting citalopram in patients with congestive heart failure, bradyarrhythmias, a history of long QTc syndrome, or concurrent use of other QTc-prolonging psychotropics such as thioridazine, ziprasidone, or haloperidol.

• Comparison of SSRI Cardiac Risk ProfilesHigh risk: citalopram possesses the highest dose-dependent QTc prolongation risk among SSRIs, requiring strict 20 mg and 40 mg caps.

  • High risk: citalopram possesses the highest dose-dependent QTc prolongation risk among SSRIs, requiring strict 20 mg and 40 mg caps.
  • Moderate risk: escitalopram causes QTc prolongation at higher doses, capped at 20 mg daily for adults and 10 mg daily for geriatric patients.
  • Low risk: sertraline, fluoxetine, and paroxetine carry minimal QTc risk at standard therapeutic doses, making sertraline a preferred first-line SSRI in patients with complex cardiovascular disease or post-myocardial infarction.
• Medical Monitoring IntervalsObtain a baseline 12-lead ECG before starting tricyclic antidepressants like amitriptyline or imipramine, prior to lithium initiation in patients over 40 or with cardiac history, and when combining QTc-prolonging psychotropics.

  • Obtain a baseline 12-lead ECG before starting tricyclic antidepressants like amitriptyline or imipramine, prior to lithium initiation in patients over 40 or with cardiac history, and when combining QTc-prolonging psychotropics.
  • Cap citalopram at a maximum daily dose of 20 mg in adults aged 60 and older, as well as in poor CYP2C19 metabolizers, due to dose-dependent QTc prolongation and risk of Torsades de Pointes.
  • Discontinue the offending psychotropic immediately, obtain an emergent 12-lead ECG, check serum potassium and magnesium levels, and refer for emergency medical evaluation if the QTc interval exceeds 500 milliseconds or increases by more than 60 milliseconds from baseline.
  • Baseline metabolic monitoring for second-generation antipsychotics requires measuring weight, body mass index, waist circumference, blood pressure, fasting plasma glucose, and lipid panel. Recheck fasting glucose and lipids at 12 weeks, then annually.
  • Screen personal and family cardiac history, baseline blood pressure, and heart rate prior to initiating stimulants like methylphenidate or amphetamine mixtures to rule out structural heart defects and sudden cardiac death risk.
  • Rule out cardiovascular medical mimics such as myocardial infarction, pulmonary embolism, pheochromocytoma, and arrhythmias prior to diagnosing a primary anxiety disorder when a patient presents with new-onset autonomic hyperarousal.
• Baseline ECG and QTc Prolongation RulesSafety alert: QTc prolongation increases the risk of Torsades de Pointes, a fatal ventricular arrhythmia.

  • Safety alert: QTc prolongation increases the risk of Torsades de Pointes, a fatal ventricular arrhythmia.
  • Normal QTc intervals are under 450 milliseconds for men and under 470 milliseconds for women.
  • First-line management: Obtain a baseline 12-lead ECG prior to starting tricyclic antidepressants, ziprasidone, or when initiating citalopram in patients with underlying cardiac conditions.
  • If the baseline QTc is normal, repeat the ECG after reaching steady-state therapeutic dosing or when adding another QTc-prolonging agent.

  Board trap. Do not increase the dose of citalopram above 20 mg daily in adults over 60 years old. Selecting a dose of 40 mg in an older adult is a classic board distractor that increases cardiac risk without providing clinical benefit.

  Safety. QTc prolongation increases the risk of Torsades de Pointes, a fatal ventricular arrhythmia. Normal QTc intervals are under 450 milliseconds for men and under 470 milliseconds for women.

• Clozapine Cardiac Monitoring and Emergency DiscontinuationSafety alert: Clozapine carries black box warnings for fatal myocarditis and cardiomyopathy, with the highest risk occurring during the first 4 to 6 weeks of treatment.

  • Safety alert: Clozapine carries black box warnings for fatal myocarditis and cardiomyopathy, with the highest risk occurring during the first 4 to 6 weeks of treatment.
  • First-line management: Prior to clozapine initiation, obtain a baseline ECG, absolute neutrophil count, baseline troponin, and C-reactive protein.
  • When to stop the drug, get an ECG, or refer: Immediately discontinue clozapine and refer the patient for emergency medical evaluation if they report chest pain, shortness of breath, rapid breathing, fever, or persistent tachycardia.
  • Order an urgent troponin, C-reactive protein, and 12-lead ECG.

  Board trap. Confusing clozapine-induced myocarditis with a viral upper respiratory infection or benign flu-like illness. Ignoring early cardiac symptoms like fever and tachycardia during the first month of clozapine therapy can lead to fatal heart failure.

  Safety. Clozapine carries black box warnings for fatal myocarditis and cardiomyopathy, with the highest risk occurring during the first 4 to 6 weeks of treatment.

• Metabolic and Endocrine Monitoring Intervals for AntipsychoticsSafety alert: Second-generation antipsychotics, particularly olanzapine and clozapine, carry high risks for weight gain, type 2 diabetes mellitus, and dyslipidemia.

  • Safety alert: Second-generation antipsychotics, particularly olanzapine and clozapine, carry high risks for weight gain, type 2 diabetes mellitus, and dyslipidemia.
  • First-line management: At baseline, obtain personal and family history, weight, body mass index, waist circumference, blood pressure, fasting plasma glucose, and fasting lipid panel.
  • Recheck weight at every visit for the first 3 months, then quarterly.
  • Recheck fasting plasma glucose and lipid panel at 12 weeks after initiation, and then annually thereafter.

  Board trap. Waiting a full year to recheck lab work after starting olanzapine. The standard protocol requires rechecking fasting glucose and lipids at 12 weeks to catch early metabolic disruption.

  Safety. Second-generation antipsychotics, particularly olanzapine and clozapine, carry high risks for weight gain, type 2 diabetes mellitus, and dyslipidemia.

• Lithium Cardiac and Organ System MonitoringSafety alert: Lithium can cause sinus node dysfunction, flattened T waves, hypothyroidism, and renal impairment.

  • Safety alert: Lithium can cause sinus node dysfunction, flattened T waves, hypothyroidism, and renal impairment.
  • Toxicity occurs when serum levels exceed 1.5 mEq/L.
  • First-line management: Obtain baseline 12-lead ECG (especially in patients over 40 or with cardiac disease), renal function tests including eGFR and serum creatinine, thyroid-stimulating hormone, serum electrolytes, and pregnancy testing.
  • Monitoring intervals: Draw serum lithium levels 12 hours post-dose (trough level) 5 to 7 days after initiation or dose changes.

  Board trap. Relying on serum creatinine alone to assess renal function in an older adult on lithium. Serum creatinine can remain artificially normal due to age-related muscle loss even when eGFR is significantly reduced. Always check eGFR.

  Safety. Lithium can cause sinus node dysfunction, flattened T waves, hypothyroidism, and renal impairment. Toxicity occurs when serum levels exceed 1.5 mEq/L.

• Stimulant Cardiac Screening in Pediatric and Adult ADHDSafety alert: Central nervous system stimulants can elevate heart rate and blood pressure, posing risks for patients with occult structural cardiac abnormalities.

  • Safety alert: Central nervous system stimulants can elevate heart rate and blood pressure, posing risks for patients with occult structural cardiac abnormalities.
  • First-line management: Perform a thorough personal and family cardiovascular history screening for unexplained syncope, exertional chest pain, arrhythmias, or premature sudden cardiac death under age 40.
  • Measure baseline blood pressure and heart rate.
  • Discontinue stimulant therapy if exertional chest pain or syncope occurs during treatment.

  Board trap. Ordering a routine screening ECG for every healthy child before starting methylphenidate without any cardiac risk factors. A routine ECG is not indicated unless personal or family cardiac risk factors are identified during history taking.

  Safety. Central nervous system stimulants can elevate heart rate and blood pressure, posing risks for patients with occult structural cardiac abnormalities.

• QTc Prolongation vs. Clozapine MyocarditisThink QTc Prolongation when: Asymptomatic ECG finding or sudden syncope linked to citalopram, tricyclic antidepressants, or ziprasidone.

  • Think QTc Prolongation when: Asymptomatic ECG finding or sudden syncope linked to citalopram, tricyclic antidepressants, or ziprasidone.
  • Think Clozapine Myocarditis when: Symptomatic clinical presentation with chest pain, dyspnea, fever, and tachycardia within the first 4 to 6 weeks of clozapine therapy.
  • Priority difference: QTc prolongation requires monitoring ECG intervals and stopping the drug if QTc exceeds 500 milliseconds. Clozapine myocarditis requires immediate drug cessation, emergency department referral, and measuring cardiac inflammatory markers like troponin and CRP.
  • Boards are testing: Recognizing which drug causes silent arrhythmia risk versus active cardiac tissue inflammation.
• Metabolic Monitoring vs. Renal/Thyroid MonitoringThink Metabolic Monitoring when: Prescribing second-generation antipsychotics like olanzapine, quetiapine, or clozapine. Recheck glucose and lipids at 12 weeks, then annually.

  • Think Metabolic Monitoring when: Prescribing second-generation antipsychotics like olanzapine, quetiapine, or clozapine. Recheck glucose and lipids at 12 weeks, then annually.
  • Think Renal and Thyroid Monitoring when: Prescribing lithium. Check baseline eGFR, serum creatinine, and TSH, then recheck every 6 to 12 months.
  • Priority difference: Metabolic risk drives cardiovascular disease over years, whereas lithium toxicity or renal clearance decline can occur rapidly with dehydration or drug interactions.
  • Boards are testing: Selecting the correct baseline and follow-up lab panel for specific drug classes.
• Medical Mimics of Panic and AnxietyThe ANCC exam consists of 175 total questions (150 scored, 25 unscored pretest) with a 3.5-hour time limit.

  • The ANCC exam consists of 175 total questions (150 scored, 25 unscored pretest) with a 3.5-hour time limit.
  • The AANPCB exam consists of 150 total questions (135 scored, 15 unscored pretest) with a 3.0-hour time limit.
  • Both exams integrate non-psychiatric body systems, requiring candidates to evaluate the cardiovascular and endocrine systems alongside psychiatric presentations.
  • The primary healthcare rule dictates intervening at the lowest level of prevention possible.
  • Primary prevention prevents health problems before they occur, such as administering the influenza vaccine or counseling on safety.
  • Secondary prevention detects disease in an early, asymptomatic state through screening, such as administering the PHQ-9 or checking a lipid profile.
• Core Exam ArchitectureQuestions testing physical assessment skills will incorporate secondary classifications. Candidates must recognize cardiovascular and endocrine mimics or drug side effects before attributing symptoms solely to a primary psychiatric disorder.

  • Questions testing physical assessment skills will incorporate secondary classifications. Candidates must recognize cardiovascular and endocrine mimics or drug side effects before attributing symptoms solely to a primary psychiatric disorder.

  Safety. Questions testing physical assessment skills will incorporate secondary classifications. Candidates must recognize cardiovascular and endocrine mimics or drug side effects before attributing symptoms solely to a primary psychiatric disorder.

• Chapter Bottom LineGate 1 Assessment Principle: Always rule out physical and medical causes first before diagnosing a primary psychiatric disorder when a patient presents with autonomic hyperarousal, chest tightness, or panic-like symptoms.

  • Gate 1 Assessment Principle: Always rule out physical and medical causes first before diagnosing a primary psychiatric disorder when a patient presents with autonomic hyperarousal, chest tightness, or panic-like symptoms.
  • Medical and Cardiac Mimics: Physical conditions that directly mimic acute anxiety or panic attacks include myocardial infarction, pulmonary embolism, pheochromocytoma, hyperthyroidism, cardiac arrhythmias, and mitral valve prolapse .
  • Substance and Medication Triggers: Screen for sympathomimetics, stimulants, caffeine, levodopa, digitalis toxicity, and antipsychotic-induced akathisia, as well as withdrawal states from alcohol or sedatives .
  • Black Box Warnings: Clozapine carries black box warnings for severe myocarditis and cardiomyopathy, requiring immediate drug discontinuation if the patient develops dyspnea, fever, chest pain, palpitations, or unexplained fatigue .
  • Eating Disorder Cardiac Risks: Anorexia nervosa causes severe cardiovascular instability including sinus bradycardia, hypotension, QTc prolongation, and mitral valve prolapse .
• Gate 1 Assessment and Look-Alike Cardiac vs Anxiety PresentationsGate 1 requires ruling out the body first. Is this an underlying cardiac, endocrine, or pulmonary emergency? Never assume a presentation is primary psychiatric until physical instability is excluded.

  • Gate 1 requires ruling out the body first. Is this an underlying cardiac, endocrine, or pulmonary emergency? Never assume a presentation is primary psychiatric until physical instability is excluded.
  • Gate 2 requires ruling out substance ingestion, intoxication, or withdrawal within the past month .
  • Gate 3 evaluates the stressor timeline. Symptoms emerging within 3 months of a stressor point to adjustment disorder with anxious mood .
  • Gate 4 considers chronic primary anxiety conditions, including generalized anxiety disorder, panic disorder, social anxiety disorder, OCD, and PTSD .
  • Gate 5 applies the 1-month trauma duration threshold to separate acute stress disorder from PTSD .
• Medical and Cardiac MimicsMyocardial infarction and cardiac arrhythmias present with acute chest pressure, dyspnea, and autonomic surges, perfectly mimicking panic attacks .

  • Myocardial infarction and cardiac arrhythmias present with acute chest pressure, dyspnea, and autonomic surges, perfectly mimicking panic attacks .
  • Pheochromocytoma produces episodic paroxysms of severe hypertension, headache, sweating, and palpitations due to catecholamine surges .
  • Hyperthyroidism causes chronic tachycardia, tremor, heat intolerance, weight loss, and severe anxiety .
  • Mitral valve prolapse often co-occurs with panic-like anxiety and autonomic instability .
  • Anorexia nervosa leads to structural and electrical cardiac changes including sinus bradycardia, hypotension, and QTc prolongation .
• Psychotropic Cardiovascular Safety ComparisonClozapine stands apart with black box warnings for fatal non-ischemic myocarditis and cardiomyopathy, demanding immediate cessation if chest pain, fever, or dyspnea develop .

  • Clozapine stands apart with black box warnings for fatal non-ischemic myocarditis and cardiomyopathy, demanding immediate cessation if chest pain, fever, or dyspnea develop .
  • Lithium requires baseline ECG, eGFR, and TSH before starting therapy .
  • CNS stimulants used for ADHD require pre-treatment screening of blood pressure, heart rate, and personal or family history of sudden cardiac death or structural heart defects .
• D) Refer the patient to cognitive behavioral therapy for panic managementQuick Answer: Obtain vital signs, physical assessment, ECG, and laboratory workup first to rule out physical causes.

  • Quick Answer: Obtain vital signs, physical assessment, ECG, and laboratory workup first to rule out physical causes.
  • Key Clue: Sudden onset at age 48 with no prior psychiatric history.
  • Best Answer: C. Obtain vital signs, perform a physical assessment, and order a 12-lead ECG and thyroid panel.
  • Why the Other Choices Are Wrong:
  • A: Initiating sertraline is premature before completing the medical rule-out assessment.
  • B: Prescribing a benzodiazepine without excluding acute cardiac pathology is unsafe and delays diagnostic clarity.
• C) 40 mgQuick Answer: The maximum daily dose of citalopram in adults aged 60 and older is 20 mg .

  • Quick Answer: The maximum daily dose of citalopram in adults aged 60 and older is 20 mg .
  • Key Clue: Age 62.
  • Best Answer: B. 20 mg.
  • Why It Is Correct: For adults aged 60 years and older, the maximum recommended dose of citalopram is 20 mg daily due to the risk of dose-dependent QTc prolongation and torsades de pointes .
  • Why the Other Choices Are Wrong:
  • A: 10 mg is a starting dose, not the maximum daily limit .
• C) Add an antibiotic for suspected community-acquired pneumoniaQuick Answer: Discontinue clozapine immediately and assess for myocarditis .

  • Quick Answer: Discontinue clozapine immediately and assess for myocarditis .
  • Key Clue: Clozapine therapy with fever, dyspnea, and chest pain.
  • Best Answer: B. Discontinue clozapine immediately and evaluate for myocarditis.
  • Why It Is Correct: Clozapine carries a black box warning for myocarditis and cardiomyopathy . Unexplained chest pain, dyspnea, fever, or tachycardia requires immediate drug discontinuation and urgent cardiac evaluation .
  • Why the Other Choices Are Wrong:
  • A: Reducing the dose is unsafe when life-threatening myocarditis is suspected .
• Anorexia Diagnostic Clue PatternsAdmission Thresholds for Bradycardia: A resting heart rate under 40 beats per minute, systolic blood pressure under 90 mmHg, orthostatic blood pressure drop greater than 20 mmHg upon standing, or active cardiac dysrhythmias trigger immediate medical inpatient admission.

  • Admission Thresholds for Bradycardia: A resting heart rate under 40 beats per minute, systolic blood pressure under 90 mmHg, orthostatic blood pressure drop greater than 20 mmHg upon standing, or active cardiac dysrhythmias trigger immediate medical inpatient admission.
  • ECG Conduction Abnormalities: Cardiac emaciation leads to QTc prolongation (greater than 470 milliseconds in females or 450 milliseconds in males), ST-segment depression, and T-wave inversion, significantly elevating the risk for Torsades de Pointes and sudden cardiac death.
  • Gate One Prioritization: Always complete Gate 1 medical and physical assessment (vital signs, BMI, serum electrolytes, and baseline ECG) to rule out cardiovascular instability before diagnosing a primary anxiety disorder or initiating psychopharmaceutical agents.
• Autonomic and Vital Sign Patterns1. Anorexia Nervosa Pattern:

  • 1. Anorexia Nervosa Pattern:
  • Heart Rate: Sinus bradycardia (resting HR under 50 beats per minute). Severe starvation increases vagal tone and decreases basal metabolic rate to conserve energy.
  • Blood Pressure: Hypotension (BP under 90/60 mmHg) and orthostatic changes (systolic drop greater than 20 mmHg or diastolic drop greater than 10 mmHg upon standing).
  • Body Mass Index and Habitus: BMI under 18.5 kg/m2 (severe under 15 kg/m2), presence of lanugo hair, muscle wasting, dry skin, and cold intolerance with hypothermia.
  • Pathophysiology: Starvation induces catabolism of cardiac myocytes, resulting in left ventricular atrophy, decreased cardiac output, and reduced stroke volume.
  • 2. Panic Disorder / Primary Anxiety Pattern:
• Electrocardiogram (ECG) and Structural CluesST-T Wave Alterations: Low voltage QRS complexes, ST-segment depression, and T-wave inversions reflect myocardial atrophy and ischemia.

  • ST-T Wave Alterations: Low voltage QRS complexes, ST-segment depression, and T-wave inversions reflect myocardial atrophy and ischemia.
• Laboratory and Refeeding TriggersPurging Sequelae: Recurrent vomiting or laxative abuse causes hypokalemic, hypochloremic metabolic alkalosis, generating frequent ventricular ectopic beats and cardiac standstill.

  • Purging Sequelae: Recurrent vomiting or laxative abuse causes hypokalemic, hypochloremic metabolic alkalosis, generating frequent ventricular ectopic beats and cardiac standstill.
• Lithium Toxicity Emergency CluesThe selected Fitzgerald prequel sources focus on exam architecture, domain weighting, and levels of prevention.

  • The selected Fitzgerald prequel sources focus on exam architecture, domain weighting, and levels of prevention.
  • Lithium dose adjustment in an established diagnosis of bipolar disorder represents tertiary prevention aimed at minimizing disease complications.
  • The ANCC exam consists of 175 total items (150 scored, 25 pretest) over 3.5 hours.
  • The AANPCB exam consists of 150 total items (135 scored, 15 pretest) over 3.0 hours.
  • Primary prevention aims to prevent disease onset, such as administering vaccines or providing safety counseling.
  • Secondary prevention focuses on early disease detection through screening tools like blood pressure checks, mammograms, or the PHQ-9.
• First-Line StrategyIntervene at the lowest level of prevention possible whenever evaluating patient care scenarios on certification exams.

  • Intervene at the lowest level of prevention possible whenever evaluating patient care scenarios on certification exams.